IMCR (IMCR) Stock Price & Analysis
IMCR (IMCR) fell 3.83% to USD 36.13 as of September 8, 2026 at 07:37 UTC, according to Nexqual real-time market data.
IMCR last closed at USD 36.13; the session ranged USD 35.98–37.43 on volume of 231,712 shares. Market capitalization is —, with a 52-week range of USD 27.56–40.72 (NMS). Source: Nexqual, September 8, 2026 at 07:37 UTC.
Key Statistics (as of September 8, 2026 at 07:37 UTC)
| Price | USD 36.13 |
|---|---|
| Change | ▼ 3.83% (down) |
| Previous Close | USD 36.13 |
| Open | USD 36.13 |
| Day Range | USD 35.98 – 37.43 |
| 52-Week Range | USD 27.56 – 40.72 |
| Volume | 231,712 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (IMCR)
Nexqual's technical model rates IMCR "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 07:37 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 51.11 (neutral) |
| vs SMA50 | Above (USD 34.46) |
| MACD | 0.83 (positive) |
From IMCR's Latest SEC 10-K Filing (filed 2026-02-25)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | USD 22.09 | ▼ 1.07% |
| VOR | Vor Biopharma Inc. | USD 25.05 | ▲ 1.17% |
| DSGN | Design Therapeutics, Inc. | USD 15.14 | ▼ 2.51% |
| PCVX | Vaxcyte, Inc. | USD 61.16 | ▼ 0.68% |
| KYMR | Kymera Therapeutics, Inc. | USD 117.39 | ▼ 1.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:37 UTC. This page is informational and not investment advice.